Search Results

Filter
  • 1-10 of  104,895 results for ""Carcinoma, Non-Small-Cell Lung""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.

  • Authors : Han X; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, The People's Republic of China.; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, The People's Republic of China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnostic imaging

  • Source: European radiology [Eur Radiol] 2024 Apr; Vol. 34 (4), pp. 2716-2726. Date of Electronic Publication: 2023 Sep 22.Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer.

  • Authors : Li Y; School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China. Electronic address: .; Sun H

Subjects: Artemisinins*/Artemisinins*/Artemisinins*/pharmacology ; Artemisinins*/Artemisinins*/Artemisinins*/therapeutic use ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 30; Vol. 133, pp. 112157. Date of Electronic Publication: 2024 Apr 27.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Reniformin A suppresses non-small cell lung cancer progression by inducing TLR4/NLRP3/caspase-1/GSDMD-dependent pyroptosis.

  • Authors : Zhu H; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Henan University of Chinese Medicine, Zhengzhou 450046, China.; Guan Y

Subjects: NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism ; Toll-Like Receptor 4*/Toll-Like Receptor 4*/Toll-Like Receptor 4*/metabolism ; Pyroptosis*/Pyroptosis*/Pyroptosis*/drug effects

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 30; Vol. 133, pp. 112068. Date of Electronic Publication: 2024 Apr 15.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

JAML promotes the antitumor role of tumor-resident CD8 + T cells by facilitating their innate-like function in human lung cancer.

  • Authors : Hao Z; Department of Thoracic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, China; Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, China.

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/immunology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: Cancer letters [Cancer Lett] 2024 May 28; Vol. 590, pp. 216839. Date of Electronic Publication: 2024 Apr 01.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer.

  • Authors : Gao GB; The Key Laboratory of Advanced Interdisciplinary Studies, The State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510530, China.; Chen L

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: Cancer letters [Cancer Lett] 2024 May 28; Vol. 590, pp. 216826. Date of Electronic Publication: 2024 Apr 02.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.

  • Authors : Yin Y; Department of Oncology, Yue Yang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Wang Y

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 May 23; Vol. 326, pp. 117984. Date of Electronic Publication: 2024 Feb 29.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway.

  • Authors : Wang H; The Second Hospital of Dalian Medical University, Dalian, 116023, China.; Guangzhou women and children's medical center, Guangzhou Medical University, Guangzhou, 510623, China.

Subjects: ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/metabolism ; ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/antagonists & inhibitors ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Respiratory research [Respir Res] 2024 May 20; Vol. 25 (1), pp. 215. Date of Electronic Publication: 2024 May 20.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway.

  • Authors : Wei S; Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.; Ai M

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism ; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)*/Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)*/Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)*/metabolism

  • Source: Carcinogenesis [Carcinogenesis] 2024 May 19; Vol. 45 (5), pp. 324-336.Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunotherapy in frail non-small-cell lung cancer patients.

  • Authors : Gijtenbeek RG; Department of Respiratory Medicine, Medical Center Leeuwarden, Leeuwarden 8934 AD, Netherlands. Electronic address: .; Noordhof AL

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/immunology

  • Source: Lancet (London, England) [Lancet] 2024 May 18; Vol. 403 (10440), pp. 1986.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

Record details

×
Academic Journal

Mitochondrial respiratory function is preserved under cysteine starvation via glutathione catabolism in NSCLC.

  • Authors : Ward NP; Department of Metabolism & Physiology, Moffitt Cancer Center, Tampa, FL, USA. .; Yoon SJ

Subjects: Cysteine*/Cysteine*/Cysteine*/metabolism ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism ; Glutathione*/Glutathione*/Glutathione*/metabolism

  • Source: Nature communications [Nat Commun] 2024 May 18; Vol. 15 (1), pp. 4244. Date of Electronic Publication: 2024 May 18.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  104,895 results for ""Carcinoma, Non-Small-Cell Lung""